CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
173.34
1.11%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.72
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 175.28
Open 173.9
1-Year Change 39.26%
Day's Range 173.34 - 175.39
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 21, 2025 175.28 2.34 1.35% 172.94 176.89 172.27
Jan 17, 2025 170.91 1.65 0.97% 169.26 173.22 168.23
Jan 16, 2025 169.73 2.78 1.67% 166.95 175.25 163.30
Jan 15, 2025 171.76 6.65 4.03% 165.11 173.59 164.93
Jan 14, 2025 165.18 0.76 0.46% 164.42 168.34 163.52
Jan 13, 2025 165.18 2.23 1.37% 162.95 166.01 162.83
Jan 10, 2025 165.56 1.17 0.71% 164.39 167.96 164.39
Jan 8, 2025 168.04 2.52 1.52% 165.52 169.32 162.54
Jan 7, 2025 164.42 -6.11 -3.58% 170.53 173.01 164.42
Jan 6, 2025 170.94 1.91 1.13% 169.03 175.01 169.02
Jan 3, 2025 170.42 2.93 1.75% 167.49 171.85 166.17
Jan 2, 2025 167.93 3.25 1.97% 164.68 170.18 163.70
Dec 31, 2024 165.04 -1.89 -1.13% 166.93 167.92 163.66
Dec 30, 2024 167.68 0.65 0.39% 167.03 170.26 165.99
Dec 27, 2024 170.91 3.28 1.96% 167.63 171.73 167.63
Dec 26, 2024 170.10 4.40 2.66% 165.70 171.90 164.23
Dec 24, 2024 167.59 2.41 1.46% 165.18 168.48 165.18
Dec 23, 2024 166.45 0.02 0.01% 166.43 169.69 165.36
Dec 20, 2024 169.44 3.95 2.39% 165.49 173.02 164.94
Dec 19, 2024 168.99 0.46 0.27% 168.53 172.47 165.89

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Masimo Corporation Company profile

About Masimo Corporation

Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive technologies and hospital automation solutions. Its patient monitoring solution that incorporates a monitor or circuit board, single-patient use or reusable sensors, software and cables. The Company’s main products include Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include noninvasive monitoring of blood constituents with an optical signature, optical regional oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring, exhaled gas monitoring, nasal high flow ventilation, minimally invasive neuromodulation technology for pain. It sells its products hospitals, emergency medical service (EMS) providers, home care providers, long-term care facilities, physician offices, veterinarians and consumers through direct sales force, distributors and original equipment manufacturers (OEM) partners.

Financial summary

BRIEF: For the fiscal year ended 01 January 2022, Masimo Corporation revenues increased 8% to $1.24B. Net income decreased 4% to $229.6M. Revenues reflect United States segment increase of 8% to $822.4M, Asia and Australia segment increase of 19% to $123.6M. Net income was offset by Selling, General & Admin Exp increase of 16% to $355M (expense), Research and Development Expense - Balan increase of 15% to $124.8M (expense).

Equity composition

Common Stock $.001 Par, 4/11, 100M auth., 59,736,034 issd., less 156,240 shs. in Treas. @ $1.2M. Insiders own 9.23%. IPO 08/08/2007, 11.9MShares @ $17per share by PiperJaffray & Co and Deutsche Bank Securities Inc. 5/07, 3-for-1 forward stock split.

Industry: Medical Equipment

52 Discovery
IRVINE
CALIFORNIA 92618
US

People also watch

XRP/USD

3.18 Price
-0.020% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01587

ETH/USD

3,266.38 Price
-1.540% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

US100

21,869.80 Price
+1.240% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,758.55 Price
+0.410% 1D Chg, %
Long position overnight fee 0.0050%
Short position overnight fee -0.0132%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 680,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading